Arleth Miranda-Lopez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arleth Miranda-Lopez has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Mauricio Comas-Garcia
Universidad Autónoma de San Luis Potosí
2 shared publications - Sergio Rosales-Mendoza
Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Manuel Nava 6, San Luis Potosí 78210, Mexico
2 shared publications - Adriana Elizabeth Monsiváis-Urenda
Molecular and Translational Medicine, Center for Research in Health Sciences and Biomedicine, Faculty of Medicine Universidad Autonoma de San Luis Potosi San Luis Potosi Mexico
1 shared publication - Ana Sonia Silva-Ramírez
Laboratorio de Células Troncales Humanas, CIACYT-Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
1 shared publication - Claudia Guadalupe Castillo‐Martín del Campo
Facultad de Medicina‐CIACYT UASLP Av. Sierra Leona 550‐2ª, Lomas de San Luis San Luis Potosí S.L.P. 78210 México
1 shared publication - Daniel Ernesto Noyola
Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autonoma de San Luis Potosi, San Luis Potosi 78210, Mexico
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (21) , 1419
Surface Chemistry Engineering of Layered Double Hydroxides for Antigen Adsorption in Zika Virus Nanovaccine Development
Layered double hydroxides (LDH) are promising nanocarriers for vaccine delivery due to their biocompatibility and tunable surface properties. This study evaluated LDH and surface-functionalized derivatives containing amino (LDH–NH2) and carboxyl (LDH–COOH) groups as delivery platforms for a recombinant Zika virus (ZIKV) antigen (rpZDIII). The nanoparticles were synthesized by coprecipitation/hydrothermal treatment and afterward functionalized via silanization and succinylation. Their physicochemical characterization included hydrodynamic size, ζ potential, point of zero charge, and amine concentration, along with Fourier-transform infrared spectroscopy and thermogravimetric analyses. Protein adsorption was evaluated using bovine serum albumin, α-chymotrypsin, and the recombinant antigen rpZDIII. Cytotoxicity and immunogenicity were evaluated in HEK-293T cells and BALB/c mice, respectively. The functionalization affected the protein adsorption capacity and its retention after washing. The adsorption of rpZDIII was best described by the Freundlich model, with LDH–NH2 having the highest antigen adsorption and retention. All three formulations maintained high cell viability at lower nanoparticle concentrations (12.5–50 μg/mL). Immunization studies demonstrated that all nanoparticle formulations elicited strong antibody responses against rpZDIII; however, only unmodified LDH-induced antibodies were able to bind the full-length recombinant ZIKV envelope protein. These findings demonstrate that the surface chemistry of LDH influences the adsorption of antigens, their retention, and their further immune recognition, highlighting the importance of preserving antigen accessibility during the design of LDH-based nanovaccines.
- 4 November 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (21) , 1419
Open AccessSurface Chemistry Engineering of Layered Double Hydroxides for Antigen Adsorption in Zika Virus Nanovaccine Development
Layered double hydroxides (LDH) are promising nanocarriers for vaccine delivery due to their biocompatibility and tunable surface properties. This study evaluated LDH and surface-functionalized derivatives containing amino (LDH–NH2) and carboxyl (LDH–COOH) groups as delivery platforms for a recombinant Zika virus (ZIKV) antigen (rpZDIII). The nanoparticles were synthesized by coprecipitation/hydrothermal treatment and afterward functionalized via silanization and succinylation. Their physicochemical characterization included hydrodynamic size, ζ potential, point of zero charge, and amine concentration, along with Fourier-transform infrared spectroscopy and thermogravimetric analyses. Protein adsorption was evaluated using bovine serum albumin, α-chymotrypsin, and the recombinant antigen rpZDIII. Cytotoxicity and immunogenicity were evaluated in HEK-293T cells and BALB/c mice, respectively. The functionalization affected the protein adsorption capacity and its retention after washing. The adsorption of rpZDIII was best described by the Freundlich model, with LDH–NH2 having the highest antigen adsorption and retention. All three formulations maintained high cell viability at lower nanoparticle concentrations (12.5–50 μg/mL). Immunization studies demonstrated that all nanoparticle formulations elicited strong antibody responses against rpZDIII; however, only unmodified LDH-induced antibodies were able to bind the full-length recombinant ZIKV envelope protein. These findings demonstrate that the surface chemistry of LDH influences the adsorption of antigens, their retention, and their further immune recognition, highlighting the importance of preserving antigen accessibility during the design of LDH-based nanovaccines.
- 2 January 2026
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 17 (1) , 69-90
The potential of organic nanoparticles and plant-derived adjuvants for vaccine design
Organic nanoparticles (NPs) are nanoscale entities composed of natural or synthetic carbon-based compounds. In biomedicine, particularly in vaccine development, their properties facilitate antigen loading, stabilization, and delivery, while exerting immunostimulatory effects that enhance immune responses. Compared to inorganic NPs, organic NPs often exhibit higher safety profiles, greater chemical versatility for functionalization, and superior mucoadhesive properties. Over the past three decades, organic NP-based nanovaccines have been increasingly explored, generating preclinical evidence demonstrating ability to induce robust immune responses and confer immunoprotection. Within this context, plant-derived compounds have attracted growing interest due to their chemical diversity and broad spectrum of bioactivities, including immunostimulatory effects, making them promising candidates as vaccine adjuvants. The data presented in this review were derived from review of peer-reviewed literature identified through searches on PubMed, Scopus, and ScienceDirect, covering studies published between 2000 and 2025, with earlier foundational studies included. This review discusses the application of organic NPs in nanovaccine platforms, detailing key properties, advantages, and the promising vaccine prototypes reported in the literature. Special attention is given to the potential of plant-derived compounds as adjuvants, highlighting their role in optimizing organic NP-based nanosystems for vaccine delivery, while providing insights into key design considerations for developing effective vaccines.
- 2 January 2026
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 17 (1) , 69-90
The potential of organic nanoparticles and plant-derived adjuvants for vaccine design
Organic nanoparticles (NPs) are nanoscale entities composed of natural or synthetic carbon-based compounds. In biomedicine, particularly in vaccine development, their properties facilitate antigen loading, stabilization, and delivery, while exerting immunostimulatory effects that enhance immune responses. Compared to inorganic NPs, organic NPs often exhibit higher safety profiles, greater chemical versatility for functionalization, and superior mucoadhesive properties. Over the past three decades, organic NP-based nanovaccines have been increasingly explored, generating preclinical evidence demonstrating ability to induce robust immune responses and confer immunoprotection. Within this context, plant-derived compounds have attracted growing interest due to their chemical diversity and broad spectrum of bioactivities, including immunostimulatory effects, making them promising candidates as vaccine adjuvants. The data presented in this review were derived from review of peer-reviewed literature identified through searches on PubMed, Scopus, and ScienceDirect, covering studies published between 2000 and 2025, with earlier foundational studies included. This review discusses the application of organic NPs in nanovaccine platforms, detailing key properties, advantages, and the promising vaccine prototypes reported in the literature. Special attention is given to the potential of plant-derived compounds as adjuvants, highlighting their role in optimizing organic NP-based nanosystems for vaccine delivery, while providing insights into key design considerations for developing effective vaccines.
- 21 April 2025
- Published by Springer Nature in Current Microbiology
- Vol. 82 (6) , 1-12
Cytomegalovirus Infection Affects the Differentiation and Determines the Functionality of a Human Progenitor Neural Cell Line
Cytomegalovirus (CMV) is a leading cause of congenital infections and one of the most common causes of neurodevelopmental disabilities worldwide. Despite the critical consequences of CMV infection in the brain, little is known about the mechanisms of neuropathogenesis responsible for malformations and dysfunction in the central nervous system. Some reports point out the infection of neural precursor cells (NPCs) as a key element in this process; these cells show the greatest susceptibility to CMV in the developing brain. In order to further characterize how CMV perturbs NPCs properties, we investigated the effect of human CMV strain AD169 in the neural stem cell cycle, viability, phenotype, and function of hNS-1 cells (immortalized cell line of human fetal brain). Notably, both infected and non-infected cells undergo apoptosis, with CMV infection not inducing a higher rate of apoptosis compared to non-infected cells. Upon infection and induction of differentiation in hNS-1 cells, the transcriptional expression of the NMDA receptor and the astrocyte marker GFAP is significantly reduced. Immunofluorescence assays corroborate the inhibition of astrocyte differentiation by CMV infection, while differentiation to neurons remains unaffected. Furthermore, our study demonstrates that CMV-infected hNS-1 cells exhibit impaired responses to multiple agonists after differentiation, including purinergic and GABAergic neurotransmission. These observations shed light on the previously understudied aspect of human CMV’s influence on NPCs’ function, providing valuable insights into the intricate interplay between CMV and neural development.
- 21 April 2025
- Published by Springer Nature in Current Microbiology
- Vol. 82 (6) , 1-12
Cytomegalovirus Infection Affects the Differentiation and Determines the Functionality of a Human Progenitor Neural Cell Line
Cytomegalovirus (CMV) is a leading cause of congenital infections and one of the most common causes of neurodevelopmental disabilities worldwide. Despite the critical consequences of CMV infection in the brain, little is known about the mechanisms of neuropathogenesis responsible for malformations and dysfunction in the central nervous system. Some reports point out the infection of neural precursor cells (NPCs) as a key element in this process; these cells show the greatest susceptibility to CMV in the developing brain. In order to further characterize how CMV perturbs NPCs properties, we investigated the effect of human CMV strain AD169 in the neural stem cell cycle, viability, phenotype, and function of hNS-1 cells (immortalized cell line of human fetal brain). Notably, both infected and non-infected cells undergo apoptosis, with CMV infection not inducing a higher rate of apoptosis compared to non-infected cells. Upon infection and induction of differentiation in hNS-1 cells, the transcriptional expression of the NMDA receptor and the astrocyte marker GFAP is significantly reduced. Immunofluorescence assays corroborate the inhibition of astrocyte differentiation by CMV infection, while differentiation to neurons remains unaffected. Furthermore, our study demonstrates that CMV-infected hNS-1 cells exhibit impaired responses to multiple agonists after differentiation, including purinergic and GABAergic neurotransmission. These observations shed light on the previously understudied aspect of human CMV’s influence on NPCs’ function, providing valuable insights into the intricate interplay between CMV and neural development.